• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT IRELAND ARCHITECT TOTAL PSA

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT IRELAND ARCHITECT TOTAL PSA Back to Search Results
Catalog Number 07K70-27
Device Problem High Test Results (2457)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 06/19/2017
Event Type  malfunction  
Manufacturer Narrative
An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.
 
Event Description
The customer stated that falsely elevated architect total psa result of 13.67 ng/ml was generated for a (b)(6) year old male patient on (b)(6) 2017.Testing was performed at another hospital (method not specified) on (b)(6)2017 and the patient's total psa result was 2.75 ng/ml.Repeat testing on architect was 13.12 ng/ml.No adverse impact to patient management was reported.
 
Manufacturer Narrative
No customer returns were available.Investigation of the customer issue included a review of the complaint text, a search for similar complaints and a review of labeling.Historical quality metrics were reviewed and no adverse trend was identified for the customer's issue.Complaint searches determined that there is normal complaint activity for the likely cause lot.Labeling was reviewed and found to be adequate.Testing of a serum based panel sample with a target concentration of 3.5 ng/ml, which mimics a patient sample, was performed using an in-house retained kit of lot 73007fn00 stored at the recommended storage condition.All specifications were met indicating that lot 73007fn00 is performing acceptably.Historical performance of the reagent lot was evaluated using world wide data from abbott link.The patient data was analyzed and compared to an established control limit.This evaluation indicated that the patient median result for this lot is within the established control limits which indicates that the lot is performing acceptably and comparable to other lots in the field.Based on the available information, no product deficiency of architect total psa, lot number 73007fn00, was identified.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARCHITECT TOTAL PSA
Type of Device
TOTAL PSA
Manufacturer (Section D)
ABBOTT IRELAND
diagnostics division
finisklin business park
sligo NA
EI  NA
Manufacturer (Section G)
ABBOTT IRELAND
diagnostics division
finisklin business park
sligo NA
EI   NA
Manufacturer Contact
noemi romero-kondos, rn bsn
100 abbott park road
dept. 09b9, lccp1-3
abbott park, IL 60064-3537
224667-512
MDR Report Key6747912
MDR Text Key81192468
Report Number3008344661-2017-00071
Device Sequence Number1
Product Code MTF
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P910007
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 08/30/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date01/23/2018
Device Catalogue Number07K70-27
Device Lot Number73007FN00
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 07/13/2017
Initial Date FDA Received07/27/2017
Supplement Dates Manufacturer Received08/29/2017
Supplement Dates FDA Received08/30/2017
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured02/20/2017
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
Treatment
ARCHITECT I2000SR ANALYZER; LIST 03M74-01, SERIAL (B)(4)
Patient Age52 YR
-
-